Showing results (1-10 of 983) with videos related to
Sort By:
Pageof 99
International Journal of Cardiology|February 15, 2012
Does the SYNTAX score get on your nerves? Practical considerations on how and when avoiding it to maximize its usefulness with no waste of timeDavide Capodanno, Corrado TamburinoRecent Patents on Drug Delivery & Formulation|November 27, 2009
Properties and clinical development of a novel coating technology: the poly[bis(trifluoroethoxy)phosphazene]Davide Capodanno, Corrado TamburinoAmerican Heart Journal|March 12, 2011
Integrating the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score into practice: use, pitfalls, and new directionsDavide Capodanno, Corrado TamburinoInterventional Cardiology Clinics|June 6, 2017
Antithrombotic Strategies in Valvular and Structural Heart Disease Interventions: Current Status and Future DirectionsDavide Capodanno, Corrado TamburinoRecenti Progressi in Medicina|January 14, 2010
[Recent advances in the knowledge of coronary flow disturbances after percutaneous coronary intervention]Davide Capodanno, Corrado TamburinoInternational Journal of Cardiology|November 15, 2011
Unraveling the EXCEL: promises and challenges of the next trial of left main percutaneous coronary interventionDavide Capodanno, Corrado TamburinoJournal of Cardiovascular Translational Research|November 26, 2013
Bridging antiplatelet therapy in patients requiring cardiac and non-cardiac surgery: from bench to bedsideDavide Capodanno, Corrado TamburinoInternational Journal of Cardiology|September 16, 2011
A focused update on emerging prognostic determinants in distal left main percutaneous coronary interventionDavide Capodanno, Valeria Calvi, Corrado TamburinoInternational Journal of Cardiology|November 10, 2009
Sirolimus- vs. paclitaxel-eluting stents in patients undergoing off-label percutaneous coronary interventionCettina Ruperto, Davide Capodanno, Corrado TamburinoRecent Patents on Cardiovascular Drug Discovery|April 20, 2013
Current status and ongoing development of reversing agents for novel oral anticoagulants (NOACs)Davide Capodanno, Giuseppe Giacchi, Corrado TamburinoPageof 99